Cottu, P., D'Hondt, V., Dureau, S., Lerebours, F., Desmoulins, I., Heudel, P. -., Duhoux, F. P., Levy, C., Mouret-Reynier, M. -., Dalenc, F., Frenel, J. -., Jouannaud, C., Venat-Bouvet, L., Nguyen, S., Ferrero, J. -., Canon, J. -., Grenier, J., Callens, C., Gentien, D., Lemonnier, J., Vincent-Salomon, A., & Delaloge, S. (2018). letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. Annals of oncology, 29, 2334–2340. http://access.bl.uk/ark:/81055/vdc_100095490818.0x000038